Javascript must be enabled to continue!
Formulation and In vitro Characterization of Floating Gel Beads of Metformin Hydrochloride
View through CrossRef
A floating type dosage form, gel beads of metformin hydrochloride was prepared by emulsification gelation technique. The gel bead was formed by mixing the polymer in water, oil phase and it was extruded in the calcium chloride solution as curing agent. The formulation parameters optimized were polymer ratio, concentration of oil, curing time on drug content, floating lag time, morphology, swelling of beads and release kinetics.The scanning electron photomicrographs revealed morphology of beads. The size of beads was measured. Entrapment efficiency of drug loaded beads was found to be over 90%. In vitro release of metformin hydrochloride from alginate–pectin beads into simulated gastric fluid at 37 ºC showed no significant burst effect. The cumulative release reached above 74.71 ± 4.15% in about 12h. The use of sodium alginate and combinations of sodium alginate with pectin were used to study the effect on the sustained release of the drug from the formed beads. It was found that sodium alginate was not sufficient to sustain the drug release at gastric pH (fed condition). Appropriate combination of alginate and pectin could provide the sustained release of drug. Floating gel beads formulation provides an alternative delivery for metformin in diabetes treatment.
BSP Books Private Limited
Title: Formulation and In vitro Characterization of Floating Gel Beads of Metformin Hydrochloride
Description:
A floating type dosage form, gel beads of metformin hydrochloride was prepared by emulsification gelation technique.
The gel bead was formed by mixing the polymer in water, oil phase and it was extruded in the calcium chloride solution as curing agent.
The formulation parameters optimized were polymer ratio, concentration of oil, curing time on drug content, floating lag time, morphology, swelling of beads and release kinetics.
The scanning electron photomicrographs revealed morphology of beads.
The size of beads was measured.
Entrapment efficiency of drug loaded beads was found to be over 90%.
In vitro release of metformin hydrochloride from alginate–pectin beads into simulated gastric fluid at 37 ºC showed no significant burst effect.
The cumulative release reached above 74.
71 ± 4.
15% in about 12h.
The use of sodium alginate and combinations of sodium alginate with pectin were used to study the effect on the sustained release of the drug from the formed beads.
It was found that sodium alginate was not sufficient to sustain the drug release at gastric pH (fed condition).
Appropriate combination of alginate and pectin could provide the sustained release of drug.
Floating gel beads formulation provides an alternative delivery for metformin in diabetes treatment.
Related Results
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract 2765: Metformin represses cancer cells via alternate pathways in N-Cadherin wild-type and N-Cadherin-deficient cells
Abstract
BACKGROUND
Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer agent...
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract PO1-05-11: Efficacy of metformin as adjunctive therapy in patients with de novo metastatic breast cancer: a retrospective cohort study
Abstract
Background: Metformin, an oral biguanide used for the treatment of type-2 diabetes mellitus (DM), has been shown in a considerable number of studies to have...
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract 4965: Metformin has an anticancer effect by repressing TWIST/N-cadherin signaling.
Abstract
Introduction and Objective. Metformin, one of the most commonly used medications for treatment of type 2 diabetes, has emerged as a potential anticancer age...
Procedure for Latex beads coating with glycolipids v1
Procedure for Latex beads coating with glycolipids v1
Goal: This document aims to standardize the protocol for latex beads coating with the Mycobacterium leprae phenolic glycolipid “PGL I”. Beads-PGL I coating is used, for example, fo...
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Morning exercise and pre-breakfast metformin interact to reduce glycaemia in people with Type 2 Diabetes: a randomized crossover trial
Abstract
Exercise is recommended in the treatment of Type 2 Diabetes and can improve insulin sensitivity [1]. However, previous evidence suggests that exercise at d...
Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study
Vitamin B12 Status in Metformin Treated Diabetics: Cross Sectional Study
Background: Metformin is the most commonly used drug for patients with type 2 diabetes mellitus (T2DM) patients. Metformin related vitamin B12 deficiency can cause anemia. Accordin...
867 Postoperative Metformin is Associated With Improved Survival of Glioblastoma Patients
867 Postoperative Metformin is Associated With Improved Survival of Glioblastoma Patients
INTRODUCTION:
Metformin may improve clinical outcomes for glioblastoma (GBM) patients as metformin showed in vitro tumor suppressor functions, such as reducing the prol...
Kajian Interaksi Obat Metformin pada Pasien Diabetes Mellitus
Kajian Interaksi Obat Metformin pada Pasien Diabetes Mellitus
Diabetes melitus merupakan penyakit degeneratif kronis yang apabila tidak ditangani dengan tepat, lama kelamaan bisa timbul berbagai komplikasi, ini cenderung menyebabkan pasien me...

